The economic burden of incident venous thromboembolism in the United States: a review of estimated attributable healthcare costs
Venous thromboembolism (VTE), which includes deep vein thrombosis and pulmonary
embolism, is an important cause of preventable mortality and morbidity. In this study, we …
embolism, is an important cause of preventable mortality and morbidity. In this study, we …
Venous thrombosis
Venous thromboembolism (VTE) encompasses deep-vein thrombosis (DVT) and pulmonary
embolism. VTE is the leading cause of lost disability-adjusted life years and the third leading …
embolism. VTE is the leading cause of lost disability-adjusted life years and the third leading …
Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism
Hokusai-VTE Investigators - New England journal of medicine, 2013 - Mass Medical Soc
Background Whether the oral factor Xa inhibitor edoxaban can be an alternative to warfarin
in patients with venous thromboembolism is unclear. Methods In a randomized, double …
in patients with venous thromboembolism is unclear. Methods In a randomized, double …
Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology
SA Kozek-Langenecker, A Afshari… - European Journal of …, 2013 - journals.lww.com
The aims of severe perioperative bleeding management are three-fold. First, preoperative
identification by anamesis and laboratory testing of those patients for whom the …
identification by anamesis and laboratory testing of those patients for whom the …
Comparison of the novel oral anticoagulants apixaban, dabigatran, edoxaban, and rivaroxaban in the initial and long-term treatment and prevention of venous …
Background Anticoagulation with low molecular weight heparin and vitamin K antagonists is
the current standard of care (SOC) for venous thromboembolism (VTE) treatment and …
the current standard of care (SOC) for venous thromboembolism (VTE) treatment and …
A systematic review and meta-analysis of the epidemiology and burden of venous thromboembolism among pregnant women
G Kourlaba, J Relakis, S Kontodimas, MV Holm… - International Journal of …, 2016 - Elsevier
Background Pregnancy-related venous thromboembolism (VTE) is one of the leading
causes of maternal morbidity and mortality. Objectives To review the epidemiology, and …
causes of maternal morbidity and mortality. Objectives To review the epidemiology, and …
Review of the cost of venous thromboembolism
MM Fernandez, S Hogue, R Preblick… - ClinicoEconomics and …, 2015 - Taylor & Francis
Background Venous thromboembolism (VTE) is the second most common medical
complication and a cause of excess length of hospital stay. Its incidence and economic …
complication and a cause of excess length of hospital stay. Its incidence and economic …
Cost-of-illness studies in chronic ulcers: a systematic review
Objective: To systematically review the published academic literature on the cost of chronic
ulcers. Methods: A literature search was conducted in MEDLINE, EMBASE, HealthSTAR …
ulcers. Methods: A literature search was conducted in MEDLINE, EMBASE, HealthSTAR …
Cost-of-illness studies of diabetes mellitus: a systematic review
CS Ng, JYC Lee, MPHS Toh, Y Ko - Diabetes research and clinical practice, 2014 - Elsevier
Background Diabetes mellitus (DM) is recognised as a major health problem. Objectives
The aims of this study are two-fold:(1) to describe the methods used in the identified cost-of …
The aims of this study are two-fold:(1) to describe the methods used in the identified cost-of …
Have venous thromboembolism rates decreased in total hip and knee arthroplasty?
JA Warren, K Sundaram, HK Anis, AF Kamath… - The Journal of …, 2020 - Elsevier
Background Venous thromboembolism (VTE) is a major cause of morbidity, mortality, and
healthcare costs in arthroplasty patients. In an effort to reduce VTEs, numerous strategies …
healthcare costs in arthroplasty patients. In an effort to reduce VTEs, numerous strategies …